Last reviewed · How we verify

sevelamer hydrochloride, sevelamer carbonate

Genzyme, a Sanofi Company · Phase 2 active Small molecule

sevelamer hydrochloride, sevelamer carbonate is a Small molecule drug developed by Genzyme, a Sanofi Company. It is currently in Phase 2 development.

At a glance

Generic namesevelamer hydrochloride, sevelamer carbonate
SponsorGenzyme, a Sanofi Company
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about sevelamer hydrochloride, sevelamer carbonate

What is sevelamer hydrochloride, sevelamer carbonate?

sevelamer hydrochloride, sevelamer carbonate is a Small molecule drug developed by Genzyme, a Sanofi Company.

Who makes sevelamer hydrochloride, sevelamer carbonate?

sevelamer hydrochloride, sevelamer carbonate is developed by Genzyme, a Sanofi Company (see full Genzyme, a Sanofi Company pipeline at /company/genzyme-a-sanofi-company).

What development phase is sevelamer hydrochloride, sevelamer carbonate in?

sevelamer hydrochloride, sevelamer carbonate is in Phase 2.

Related